Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Diana Walford recalled that upon visiting a USA manufacturing facility, the inspector and herself were very unhappy due to the lack of hygiene among other things.

  • Read more about Dr Diana Walford recalled that upon visiting a USA manufacturing facility, the inspector and herself were very unhappy due to the lack of hygiene among other things.

It appeared that there was no site examination at any of the blood collection centres in the USA.

  • Read more about It appeared that there was no site examination at any of the blood collection centres in the USA.

Dr Diana Walford stated that "if somebody applied to the Medicines Division or the licensing authority, as they actually were deemed, for a clinical trial certificate or a clinical trial exemption certificate that was to be considered. It fell to be considered by Medicines Division, whether it needed to go entirely to a Committee on Safety of Medicines Meeting I think might have depended on the product."

  • Read more about Dr Diana Walford stated that "if somebody applied to the Medicines Division or the licensing authority, as they actually were deemed, for a clinical trial certificate or a clinical trial exemption certificate that was to be considered. It fell to be considered by Medicines Division, whether it needed to go entirely to a Committee on Safety of Medicines Meeting I think might have depended on the product."

Dr Cooper (Assistant Secretary for US Health, Department of Health, Education and Welfare) commented: "We feel that the warning is quite direct and adequate; in fact, it is generally appreciated in the U.S. that every lot of this particular product is probably contaminated with hepatitis B virus."

  • Read more about Dr Cooper (Assistant Secretary for US Health, Department of Health, Education and Welfare) commented: "We feel that the warning is quite direct and adequate; in fact, it is generally appreciated in the U.S. that every lot of this particular product is probably contaminated with hepatitis B virus."

Dr John Cash wrote to the BMJ stating, "There is no doubt that the import into the United Kingdom of factor VIII concentrates derived from external sources, however well screened for hepatitis viruses, represents an unequivocal pathway by which the level of a potentially lethal infection into the whole community is being deliberately increased."

  • Read more about Dr John Cash wrote to the BMJ stating, "There is no doubt that the import into the United Kingdom of factor VIII concentrates derived from external sources, however well screened for hepatitis viruses, represents an unequivocal pathway by which the level of a potentially lethal infection into the whole community is being deliberately increased."

Dr Owen took Dr Maycock's advice on his criticism of the regional structure of the blood transfusion service which was recorded in Department of Health minutes.

  • Read more about Dr Owen took Dr Maycock's advice on his criticism of the regional structure of the blood transfusion service which was recorded in Department of Health minutes.

A DHSS meeting minutes recorded Dr Owen stressing "his personal commitment to self-sufficiency".

  • Read more about A DHSS meeting minutes recorded Dr Owen stressing "his personal commitment to self-sufficiency".

At a Haemophilia Society meeting, it was discussed that "Dr Owen stated that in 1977 we would be fully self-sufficient in concentrates. The whole question of commercial concentrates, plasmapheresis, the regional structure of the BTS, and other matters were fully discussed."

  • Read more about At a Haemophilia Society meeting, it was discussed that "Dr Owen stated that in 1977 we would be fully self-sufficient in concentrates. The whole question of commercial concentrates, plasmapheresis, the regional structure of the BTS, and other matters were fully discussed."

Reverend Tanner (Chair, Haemophilia Society) met Dr Owen and described that he "spoke very forcibly to Dr David Owen to let him know that [he was] not prepared to accept the risk of hepatitis coming from the blood products issued from the United States."

  • Read more about Reverend Tanner (Chair, Haemophilia Society) met Dr Owen and described that he "spoke very forcibly to Dr David Owen to let him know that [he was] not prepared to accept the risk of hepatitis coming from the blood products issued from the United States."

Granada screened "World in Action programme Blood Money - Part 2" documentary in the UK.

  • Read more about Granada screened "World in Action programme Blood Money - Part 2" documentary in the UK.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 754
  • Page 755
  • Page 756
  • Page 757
  • Current page 758
  • Page 759
  • Page 760
  • Page 761
  • Page 762
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.